The problem wasn't technology. It was price.
Bionic hands already existed. Multi-grip myoelectric hands sold for USD 30,000–60,000 in Western markets, and even the most affordable 3D-printed option cost around USD 13,000. For most upper-limb amputees in India, that put a functional hand out of reach entirely. The realistic option was a plastic cosmetic prosthesis — it looks like a hand, but it doesn't grip, hold or work like one.
So we set a hard target: a hand that competes on function with the bionic hands on the market, at under USD 3,000. Not cheap for the sake of cheap — a price that was at least within reach. Every engineering decision after that was measured against it.
